Les Sulewski
Stock Analyst at Truist Securities
(1.55)
# 4,011
Out of 5,182 analysts
20
Total ratings
50%
Success rate
-9.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $42 → $45 | $35.73 | +25.94% | 4 | Apr 30, 2026 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $18 | $6.28 | +186.62% | 1 | Mar 5, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $15 → $17 | $13.20 | +28.79% | 4 | Mar 2, 2026 | |
| BHC Bausch Health Companies | Maintains: Hold | $7 → $8 | $5.75 | +39.13% | 1 | Jan 7, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $23.15 | +20.95% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $37.80 | +26.98% | 3 | Nov 7, 2025 |
Teva Pharmaceutical Industries
Apr 30, 2026
Maintains: Buy
Price Target: $42 → $45
Current: $35.73
Upside: +25.94%
Vanda Pharmaceuticals
Mar 5, 2026
Initiates: Buy
Price Target: $18
Current: $6.28
Upside: +186.62%
Amneal Pharmaceuticals
Mar 2, 2026
Maintains: Buy
Price Target: $15 → $17
Current: $13.20
Upside: +28.79%
Bausch Health Companies
Jan 7, 2026
Maintains: Hold
Price Target: $7 → $8
Current: $5.75
Upside: +39.13%
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $23.15
Upside: +20.95%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $37.80
Upside: +26.98%